retatrutide for addiction vs Tirzepatide — What to Know Before You Decide VIDEO: How Can GLP-1 Agonists

The GLP-1 agonists mimic these actions, and their modified structures lead to slower elimination and a longer duration of action

Tirzepatide with niacinamide is another popular combination, where the niacinamide may support cellular energy metabolism during caloric restriction

Even without a shortage, compounded semaglutide may be marketed as an alternative, appealing to those looking for an affordable option and creating a lucrative opportunity for pharmacies

Summary: Retatrutide is an investigational triple hormone receptor agonist peptide (GLP-1, GIP, and glucagon) developed by Eli Lilly for obesity treatment, currently in Phase 3 trials and not yet approved by the MHRA or EMA

Levine emphasizes close monitoring and open communication so that any concerns are addressed promptly